Keyword: NewLink Genetics
News
16.06.2017
- US biotechnology group Genentech, part of Roche, is handing back rights to NewLink Genetics’ IDO inhibitor GDC-0919 (navoximod), an investigational cancer treatment. Genentech...
News
27.01.2016
- Geneva, Switzerland-based GAVI (Global Alliance for Vaccines and Immunization), a public-private partnership, and Merck Sharp & Dohme (MSD), known in the US as Merck & Co, have...
News
29.08.2014
- An experimental Ebola vaccine from GlaxoSmithKline is being fast-tracked into clinical trials with human patients, and the company plans to immediately begin building a stockpile...
